Celcuity IncNASDAQ:CELC
- LAST PRICE10.5700
- TODAY'S CHANGE (%)-0.1500 (-1.3993%)
- Bid / Lots9.6500/ 1
- Ask / Lots11.3500/ 1
- Open / Previous Close10.7200 / 10.7200
- Day Range
- 52 Week Range
- Volume102,900
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CELC |
|---|---|---|
| 09:32 ET | 528 | 10.51 |
| 09:33 ET | 100 | 10.99 |
| 09:39 ET | 100 | 10.99 |
| 09:46 ET | 100 | 10.56 |
| 10:04 ET | 100 | 10.52 |
| 10:06 ET | 100 | 10.52 |
| 10:11 ET | 100 | 10.75 |
| 10:18 ET | 300 | 10.55 |
| 10:20 ET | 1500 | 10.54 |
| 10:22 ET | 200 | 10.96 |
| 10:24 ET | 400 | 10.7 |
| 10:26 ET | 400 | 10.53 |
| 10:27 ET | 200 | 10.65 |
| 10:29 ET | 700 | 10.62 |
| 10:31 ET | 400 | 10.6 |
| 10:33 ET | 400 | 10.53 |
| 10:36 ET | 300 | 10.6 |
| 10:38 ET | 1400 | 10.8 |
| 10:40 ET | 1300 | 10.53 |
| 10:42 ET | 300 | 10.52 |
| 10:44 ET | 100 | 10.58 |
| 10:45 ET | 200 | 10.53 |
| 10:47 ET | 600 | 10.52 |
| 10:49 ET | 700 | 10.52 |
| 10:51 ET | 1490 | 10.5 |
| 10:54 ET | 100 | 10.35 |
| 10:56 ET | 6347 | 10.42 |
| 10:58 ET | 378 | 10.5125 |
| 11:05 ET | 100 | 10.59 |
| 11:07 ET | 100 | 10.595 |
| 11:14 ET | 400 | 10.5897 |
| 11:16 ET | 300 | 10.5897 |
| 11:21 ET | 300 | 10.59 |
| 11:23 ET | 200 | 10.5897 |
| 11:25 ET | 173 | 10.59 |
| 11:30 ET | 200 | 10.7097 |
| 11:32 ET | 200 | 10.65 |
| 11:34 ET | 200 | 10.7099 |
| 11:36 ET | 210 | 10.71 |
| 11:38 ET | 400 | 10.9797 |
| 11:39 ET | 1400 | 10.7498 |
| 11:41 ET | 700 | 10.9797 |
| 11:43 ET | 200 | 10.9 |
| 11:45 ET | 2500 | 10.86 |
| 11:48 ET | 1400 | 10.81 |
| 11:50 ET | 1127 | 10.81 |
| 11:52 ET | 700 | 10.81 |
| 11:54 ET | 2100 | 10.7 |
| 11:56 ET | 200 | 10.59 |
| 11:57 ET | 700 | 10.6907 |
| 11:59 ET | 200 | 10.59 |
| 12:01 ET | 200 | 10.6715 |
| 12:21 ET | 100 | 10.8 |
| 12:24 ET | 200 | 10.8 |
| 12:26 ET | 100 | 10.8 |
| 12:28 ET | 600 | 10.6598 |
| 12:32 ET | 1000 | 10.63 |
| 12:35 ET | 200 | 10.7197 |
| 12:37 ET | 300 | 10.7 |
| 12:39 ET | 300 | 10.9997 |
| 12:42 ET | 600 | 10.7698 |
| 12:44 ET | 1200 | 10.6 |
| 12:46 ET | 1200 | 10.8 |
| 12:48 ET | 1000 | 10.6 |
| 12:50 ET | 1200 | 10.78 |
| 12:51 ET | 1300 | 10.8 |
| 12:53 ET | 400 | 10.72 |
| 12:55 ET | 500 | 10.73 |
| 12:57 ET | 200 | 10.61 |
| 01:00 ET | 100 | 10.61 |
| 01:02 ET | 100 | 10.7 |
| 01:04 ET | 100 | 10.61 |
| 01:09 ET | 100 | 10.71 |
| 01:11 ET | 100 | 10.69 |
| 01:33 ET | 100 | 10.89 |
| 01:36 ET | 100 | 10.89 |
| 01:38 ET | 100 | 10.89 |
| 01:40 ET | 100 | 10.89 |
| 01:42 ET | 100 | 10.88 |
| 01:44 ET | 200 | 10.8697 |
| 01:45 ET | 800 | 10.7198 |
| 01:47 ET | 200 | 10.8697 |
| 01:49 ET | 400 | 10.8597 |
| 01:51 ET | 500 | 10.82 |
| 01:54 ET | 500 | 10.82 |
| 01:56 ET | 768 | 10.71 |
| 01:58 ET | 200 | 10.8597 |
| 02:00 ET | 200 | 10.8597 |
| 02:02 ET | 1300 | 10.795 |
| 02:03 ET | 500 | 10.795 |
| 02:05 ET | 1000 | 10.76 |
| 02:07 ET | 300 | 10.68 |
| 02:09 ET | 1000 | 10.76 |
| 02:12 ET | 500 | 10.7 |
| 02:14 ET | 500 | 10.7505 |
| 02:16 ET | 400 | 10.69 |
| 02:18 ET | 500 | 10.66 |
| 02:20 ET | 900 | 10.65 |
| 02:25 ET | 100 | 10.69 |
| 02:34 ET | 100 | 10.6 |
| 02:36 ET | 600 | 10.66 |
| 02:38 ET | 400 | 10.67 |
| 02:39 ET | 300 | 10.63 |
| 02:41 ET | 900 | 10.6 |
| 02:45 ET | 200 | 10.63 |
| 02:48 ET | 200 | 10.6 |
| 02:50 ET | 220 | 10.5955 |
| 02:52 ET | 200 | 10.53 |
| 02:54 ET | 1600 | 10.63 |
| 02:56 ET | 300 | 10.58 |
| 02:57 ET | 321 | 10.66 |
| 02:59 ET | 200 | 10.62 |
| 03:01 ET | 100 | 10.62 |
| 03:03 ET | 200 | 10.65 |
| 03:08 ET | 200 | 10.59 |
| 03:10 ET | 100 | 10.65 |
| 03:12 ET | 600 | 10.61 |
| 03:14 ET | 400 | 10.61 |
| 03:15 ET | 100 | 10.65 |
| 03:17 ET | 200 | 10.59 |
| 03:19 ET | 300 | 10.59 |
| 03:21 ET | 300 | 10.59 |
| 03:24 ET | 400 | 10.57 |
| 03:26 ET | 100 | 10.64 |
| 03:28 ET | 600 | 10.64 |
| 03:30 ET | 700 | 10.58 |
| 03:32 ET | 600 | 10.58 |
| 03:33 ET | 1400 | 10.58 |
| 03:35 ET | 100 | 10.63 |
| 03:39 ET | 1020 | 10.62 |
| 03:42 ET | 200 | 10.6 |
| 03:44 ET | 100 | 10.65 |
| 03:46 ET | 333 | 10.69 |
| 03:48 ET | 1000 | 10.7099 |
| 03:50 ET | 500 | 10.655 |
| 03:51 ET | 1100 | 10.7899 |
| 03:53 ET | 1000 | 10.65 |
| 03:55 ET | 1500 | 10.78 |
| 03:57 ET | 1623 | 10.695 |
| 04:00 ET | 3864 | 10.57 |
Dec 30, 2022
BRIEF-Celcuity Files For Prospectus Offering Of 24.3 Mln Shares, from 4:50PM ET on Friday Dec 30, 2022 by Thomson Reuters
4:50PM ET on Friday Dec 30, 2022 by Thomson Reuters
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Celcuity Inc | 232.3M | -4.4x | --- |
Nautilus Biotechnology Inc | 234.5M | -4.0x | --- |
Acumen Pharmaceuticals Inc | 240.2M | -4.8x | --- |
Greenwich Lifesciences Inc | 244.6M | -33.6x | --- |
Praxis Precision Medicines Inc | 219.6M | -0.9x | --- |
Cytodyn Inc | 247.0M | -1.0x | --- |
Company Information
Celcuity, Inc. is a clinical-stage biotechnology company. The Company is seeking to extend the lives of cancer patients by pursuing an integrated therapeutic (Rx) and companion diagnostic (CDx) strategy. Its therapeutic efforts are focused on developing molecularly targeted therapies that address the same cancer driver a CELsignia companion diagnostic can identify. The Company's lead therapeutic candidate is gedatolisib, a potent, reversible dual inhibitor that selectively targets all Class I isoforms of PI3K and mammalian target of rapamycin (mTOR). Its mechanism of action and pharmacokinetic properties are highly differentiated from other investigational therapies that target PI3K or mTOR alone or together. Its initial clinical development program for gedatolisib focus on the treatment of patients with hormone receptor positive (HR+), HER2-negative, advanced, or metastatic breast cancer. The Company's additional clinical development programs focus on various other tumor types.
Contact Information
- Headquarters
- 16305 36th Ave N Ste 100MINNEAPOLIS, MN, United States 55446-4285
- Phone
- 763-392-0767
- Fax
- 302-655-5049
Executives
- Chairman of the Board, Chief Executive Officer, Co-Founder
- Brian Sullivan
- Co-Founder, Chief Science Officer, Vice President, Secretary, Director
- Lance Laing
- Chief Financial Officer
- Vicky Hahne
- Independent Director
- Richard Buller
- Independent Director
- David Dalvey
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $232.3M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 21.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.72 |
EPS | $-2.38 |
Book Value | $4.61 |
P/E Ratio | -4.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
